Saturday, March 26, 2016
Through agreement, Xtant Medical will be entering cellular bone graft market with a viable cell allograft, osteovive.
Vivex will process the allograft for Xtant Medical, and Xtant Medical will provide national distribution.
Says expanding its biologics portfolio through a distribution relationship with Vivex Biomedical, Inc.
Source : reuters.com